{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:35:00Z","timestamp":1791005700423,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA033147"],"award-info":[{"award-number":["R01DA033147"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA021525"],"award-info":[{"award-number":["R01DA021525"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10461-016-1470-2","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T09:52:33Z","timestamp":1467193953000},"page":"402-409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Antiretroviral Therapy Interruption Among HIV Postive People Who Use Drugs in a Setting with a Community-Wide HIV Treatment-as-Prevention Initiative"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9555-7693","authenticated-orcid":false,"given":"Ryan","family":"McNeil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,28]]},"reference":[{"issue":"2","key":"1470_CR1","doi-asserted-by":"publisher","first-page":"e87872","DOI":"10.1371\/journal.pone.0087872","volume":"9","author":"JSG Montaner","year":"2014","unstructured":"Montaner JSG, Lima VD, Harrigan PR, Louren\u00e7o L, Yip B, Nosyk B, et al. Expansion of HAART coverage is associated with sustained decreases in HIV\/AIDS morbidity, mortality and HIV transmission: the \u201cHIV Treatment as Prevention\u201d experience in a Canadian setting. PLoS One. 2014;9(2):e87872.","journal-title":"PLoS One"},{"issue":"3","key":"1470_CR2","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1016\/S2352-3018(15)00017-X","volume":"2","author":"VD Lima","year":"2015","unstructured":"Lima VD, Louren\u00e7o L, Yip B, Hogg RS, Phillips P, Montaner JSG. AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study. Lancet HIV. 2015;2(3):e92\u20137.","journal-title":"Lancet HIV"},{"issue":"3","key":"1470_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/QAD.0000000000000537","volume":"29","author":"KC Duncan","year":"2015","unstructured":"Duncan KC, Chan KJ, Chiu CG, Montaner JSG, Coldman AJ, Cescon A, et al. HAART slows progression to anal cancer in HIV-infected MSM. AIDS. 2015;29(3):305\u201311.","journal-title":"AIDS."},{"issue":"10","key":"1470_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.7326\/0003-4819-139-10-200311180-00008","volume":"139","author":"E Wood","year":"2003","unstructured":"Wood E, Hogg RS, Yip B, Harrigan PR, O\u2019Shaughnessy MV. Montaner JSG. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4\u00a0+\u00a0cell count is 0.200 to 0.350\u00a0\u00d7\u00a0109 cells\/L. Ann Intern Med. 2003;139(10):810\u20136.","journal-title":"Ann Intern Med"},{"issue":"9740","key":"1470_CR5","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0140-6736(10)60936-1","volume":"376","author":"JSG Montaner","year":"2010","unstructured":"Montaner JSG, Lima VD, Barrios R, Yip B, Wood E, Kerr T, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376(9740):532\u20139.","journal-title":"Lancet"},{"issue":"6122","key":"1470_CR6","first-page":"966","volume":"339","author":"F Tanser","year":"2013","unstructured":"Tanser F, B\u00e4rnighausen T, Grapsa E, Zaidi J, Newell M-L. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal. S Afr Sci. 2013;339(6122):966\u201371.","journal-title":"S Afr Sci"},{"issue":"7","key":"1470_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1086\/507526","volume":"43","author":"DR Bangsberg","year":"2006","unstructured":"Bangsberg DR. Less than 95\u00a0% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43(7):939\u201341.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1470_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1001\/jama.2012.5927","volume":"308","author":"BR Yehia","year":"2012","unstructured":"Yehia BR, Fleishman JA, Metlay JP, Moore RD, Gebo KA. Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA. 2012;308(4):339\u201342.","journal-title":"JAMA"},{"issue":"6","key":"1470_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493\u2013505.","journal-title":"N Engl J Med"},{"key":"1470_CR10","doi-asserted-by":"publisher","first-page":"b1649","DOI":"10.1136\/bmj.b1649","volume":"338","author":"E Wood","year":"2009","unstructured":"Wood E, Kerr T, Marshall BD, Li K, Zhang R, Hogg RS, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649.","journal-title":"BMJ"},{"issue":"9","key":"1470_CR11","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.283.9.1175","volume":"283","author":"KM De Cock","year":"2000","unstructured":"De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283(9):1175\u201382.","journal-title":"JAMA"},{"issue":"9534","key":"1470_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0140-6736(06)69162-9","volume":"368","author":"JSG Montaner","year":"2006","unstructured":"Montaner JSG, Hogg R, Wood E, Kerr T, Tyndall M, Levy AR, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006;368(9534):531\u20136.","journal-title":"Lancet"},{"issue":"S1","key":"1470_CR13","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1758-2652-14-S1-S6","volume":"14","author":"B Williams","year":"2011","unstructured":"Williams B, Wood R, Dukay V, Delva W, Ginsburg D, Hargrove J, et al. Treatment as prevention: preparing the way. J Int AIDS Soc. 2011;14(S1):S6.","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"1470_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/COH.0b013e3283590617","volume":"7","author":"MW Hull","year":"2012","unstructured":"Hull MW, Wu Z, Montaner JSG. Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as prevention. Curr Opin HIV AIDS. 2012;7(6):579\u201386.","journal-title":"Curr Opin HIV AIDS"},{"issue":"9787","key":"1470_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0140-6736(11)60821-0","volume":"378","author":"JSG Montaner","year":"2011","unstructured":"Montaner JSG. Treatment as prevention: a double hat-trick. Lancet. 2011;378(9787):208\u20139.","journal-title":"Lancet"},{"issue":"4","key":"1470_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/jama.2012.7961","volume":"308","author":"MA Thompson","year":"2012","unstructured":"Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society\u2013USA panel. JAMA. 2012;308(4):387\u2013402.","journal-title":"JAMA"},{"key":"1470_CR17","volume-title":"Antiretroviral treatment as prevention (TASP) of HIV and TB: programmatic update","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Antiretroviral treatment as prevention (TASP) of HIV and TB: programmatic update. Geneva: World Health Organization; 2012."},{"key":"1470_CR18","volume-title":"90-90-90: an ambitious treatment target to help end the AIDS epidemic","author":"Joint United Nations Programme on HIV\/AIDS","year":"2014","unstructured":"Joint United Nations Programme on HIV\/AIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS; 2014."},{"issue":"13","key":"1470_CR19","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1097\/QAD.0000000000000746","volume":"29","author":"B Nosyk","year":"2015","unstructured":"Nosyk B, Louren\u00e7o L, Min JE, Shopin D, Lima VD, Montaner JSG, et al. Characterizing retention in HAART as a recurrent event process: insights into \u2018cascade churn\u2019. AIDS. 2015;29(13):1681\u20139.","journal-title":"AIDS"},{"key":"1470_CR20","doi-asserted-by":"publisher","first-page":"e43754","DOI":"10.1371\/journal.pone.0043754","volume":"7","author":"E Hamlyn","year":"2012","unstructured":"Hamlyn E, Ewings FM, Porter K, Cooper DA, Tambussi G, Schechter M, et al. Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection. PLoS One. 2012;7:e43754.","journal-title":"PLoS One"},{"issue":"4","key":"1470_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/QAI.0b013e3181f2ac87","volume":"55","author":"VD Lima","year":"2010","unstructured":"Lima VD, Bangsberg DR, Harrigan PR, Deeks SG, Yip B, Hogg RS, et al. Risk of viral failure declines with duration of suppression on HAART, irrespective of adherence level. J Acquir Immune Defic Syndr. 2010;55(4):460.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"1470_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1056\/NEJMra1004180","volume":"365","author":"MA Wainberg","year":"2011","unstructured":"Wainberg MA, Zaharatos GJ, Brenner BG. Development of antiretroviral drug resistance. N Engl J Med. 2011;365(7):637\u201346.","journal-title":"N Engl J Med"},{"key":"1470_CR23","first-page":"S61","volume":"13","author":"GH Friedland","year":"1999","unstructured":"Friedland GH, Williams A. Attaining higher goals in HIV treatment: the central importance of adherence. AIDS. 1999;13:S61\u201372.","journal-title":"AIDS"},{"issue":"4","key":"1470_CR24","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/COH.0b013e328354bcc8","volume":"7","author":"M-J Milloy","year":"2012","unstructured":"Milloy M-J, Montaner J, Wood E. Barriers to HIV treatment among people who use injection drugs: implications for \u2018treatment as prevention\u2019. Curr Opin HIV AIDS. 2012;7(4):332\u20138.","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"1470_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/COH.0b013e32834f9927","volume":"7","author":"E Wood","year":"2012","unstructured":"Wood E, Milloy MJ, Montaner JSG. HIV treatment as prevention among injection drug users. Curr Opin HIV AIDS. 2012;7(2):151\u20136.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"1470_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.drugpo.2009.08.003","volume":"21","author":"A Kr\u00fcsi","year":"2010","unstructured":"Kr\u00fcsi A, Wood E, Montaner J, Kerr T. Social and structural determinants of HAART access and adherence among injection drug users. Int J Drug Policy. 2010;21(1):4\u20139.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"1470_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/09540120412331319778","volume":"17","author":"T Kerr","year":"2005","unstructured":"Kerr T, Marshall A, Walsh J, Palepu A, Tyndall M, Montaner J, et al. Determinants of HAART discontinuation among injection drug users. AIDS Care. 2005;17(5):539\u201349.","journal-title":"AIDS Care"},{"issue":"1","key":"1470_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/QAI.0000000000000084","volume":"66","author":"AJ Hughes","year":"2014","unstructured":"Hughes AJ, Mattson CL, Scheer S, Beer L, Skarbinski J. Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States. J Acquir Immune Defic Syndr. 2014;66(1):80\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"1470_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/QAI.0b013e3181b628be","volume":"52","author":"M-C Kempf","year":"2009","unstructured":"Kempf M-C, Pisu M, Dumcheva A, Westfall AO, Kilby JM, Saag MS. Gender differences in discontinuation of antiretroviral treatment regimens. J Acquir Immune Defic Syndr. 2009;52(3):336\u201341.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"1470_CR30","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1007\/s10461-014-0776-1","volume":"18","author":"H Samji","year":"2014","unstructured":"Samji H, Chen Y, Salters K, Montaner JSG, Hogg RS. Correlates of Unstructured Antiretroviral Treatment Interruption in a cohort of HIV-Positive Individuals in British Columbia. AIDS Behav. 2014;18(11):2240\u20138.","journal-title":"AIDS Behav"},{"key":"1470_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.socscimed.2015.04.008","volume":"133","author":"R McNeil","year":"2015","unstructured":"McNeil R, Kerr T, Anderson S, Maher L, Keewatin C, Milloy MJ, et al. Negotiating structural vulnerability following regulatory changes to a provincial methadone program in vancouver, canada: a qualitative study. Soc Sci Med. 2015;133:168\u201376.","journal-title":"Soc Sci Med"},{"issue":"4","key":"1470_CR32","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/01459740.2011.576725","volume":"30","author":"J Quesada","year":"2011","unstructured":"Quesada J, Hart LK, Bourgois P. Structural vulnerability and health: latino migrant laborers in the United States. Med Anthropol. 2011;30(4):339\u201362.","journal-title":"Med Anthropol"},{"key":"1470_CR33","unstructured":"Joseph B, Kerr T, Puskas CM, Montaner J, Wood E, Milloy MJ. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting. AIDS Care. In press."},{"issue":"1","key":"1470_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/apc.2011.0169","volume":"26","author":"MJ Milloy","year":"2012","unstructured":"Milloy MJ, Kerr T, Bangsberg DR, Buxton J, Parashar S, Guillemi S, et al. Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting. AIDS Patient Care STDs. 2012;26(1):60\u20137.","journal-title":"AIDS Patient Care STDs"},{"issue":"3","key":"1470_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/13548506.2014.945601","volume":"20","author":"KR Claborn","year":"2015","unstructured":"Claborn KR, Meier E, Miller MB, Leffingwell TR. A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy. Psychol Health Med. 2015;20(3):255\u201365.","journal-title":"Psychol Health Med"},{"issue":"2","key":"1470_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/hiv.12173","volume":"16","author":"H Samji","year":"2015","unstructured":"Samji H, Taha TE, Moore D, Burchell AN, Cescon A, Cooper C, et al. Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada. HIV Med. 2015;16(2):76\u201387.","journal-title":"HIV Med"},{"issue":"5","key":"1470_CR37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/09540121.2013.844766","volume":"26","author":"S Hill","year":"2014","unstructured":"Hill S, Kavookjian J, Qian J, Chung A, Vandewaa J. Effects of pill burden on discontinuation of the initial HAART regimen in minority female patients prescribed 1 pill\/day versus any other pill burden. AIDS Care. 2014;26(5):595\u2013601.","journal-title":"AIDS Care"},{"issue":"5","key":"1470_CR38","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1001\/jama.300.5.550","volume":"300","author":"E Wood","year":"2008","unstructured":"Wood E, Hogg RS, Lima VD, Kerr T, Yip B, Marshall BDL, et al. Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA. 2008;300(5):550\u20134.","journal-title":"JAMA"},{"issue":"2","key":"1470_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.drugpo.2012.12.004","volume":"24","author":"AM Lopez","year":"2013","unstructured":"Lopez AM, Bourgois P, Wenger LD, Lorvick J, Martinez AN, Kral AH. Interdisciplinary mixed methods research with structurally vulnerable populations: case studies of injection drug users in San Francisco. Int J Drug Policy. 2013;24(2):101\u20139.","journal-title":"Int J Drug Policy"},{"issue":"12","key":"1470_CR40","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1111\/j.1360-0443.2009.02709.x","volume":"104","author":"D Moore","year":"2009","unstructured":"Moore D, Dray A, Green R, Hudson SL, Jenkinson R, Siokou C, et al. Extending drug ethno-epidemiology using agent-based modelling. Addiction. 2009;104(12):1991\u20137.","journal-title":"Addiction"},{"issue":"5","key":"1470_CR41","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3851\/IMP1614","volume":"15","author":"A Kr\u00fcsi","year":"2010","unstructured":"Kr\u00fcsi A, Milloy MJ, Kerr T, Zhang R, Guillemi S, Hogg R, et al. Ongoing drug use and outcomes from highly active antiretroviral therapy among injection drug users in a Canadian setting. Antivir Ther. 2010;15(5):789.","journal-title":"Antivir Ther"},{"issue":"1","key":"1470_CR42","doi-asserted-by":"publisher","first-page":"18855","DOI":"10.7448\/IAS.17.1.18855","volume":"17","author":"R McNeil","year":"2014","unstructured":"McNeil R, Dilley LB, Guirguis-Younger M, Hwang SW, Small W. Impact of supervised drug consumption services on access to and engagement with care at a palliative and supportive care facility for people living with HIV\/AIDS: a qualitative study. J Int AIDS Soc. 2014;17(1):18855.","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"1470_CR43","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1080\/09540120802511869","volume":"21","author":"W Small","year":"2009","unstructured":"Small W, Wood E, Betteridge G, Montaner J, Kerr T. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care. 2009;21(6):708\u201314.","journal-title":"AIDS Care"},{"issue":"9","key":"1470_CR44","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/infdis\/jir032","volume":"203","author":"MJ Milloy","year":"2011","unstructured":"Milloy MJ, Kerr T, Buxton J, Rhodes T, Guillemi S, Hogg R, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203(9):1215\u201321.","journal-title":"J Infect Dis"},{"issue":"1","key":"1470_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10461-012-0136-y","volume":"17","author":"D Werb","year":"2013","unstructured":"Werb D, Milloy MJ, Kerr T, Zhang R, Montaner J, Wood E. Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting. AIDS Behav. 2013;17(1):68\u201373.","journal-title":"AIDS Behav"},{"issue":"4","key":"1470_CR46","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/j.1475-6773.2006.00684.x","volume":"42","author":"EH Bradley","year":"2007","unstructured":"Bradley EH, Curry LA, Devers KJ. Qualitative data analysis for health services research: developing taxonomy, themes, and theory. Health Serv Res. 2007;42(4):1758\u201372.","journal-title":"Health Serv Res"},{"issue":"8","key":"1470_CR47","doi-asserted-by":"publisher","first-page":"F60","DOI":"10.1097\/00002030-199708000-00001","volume":"11","author":"SA Strathdee","year":"1997","unstructured":"Strathdee SA, Patrick DM, Currie SL, Cornelisse PGA, Rekart ML, Montaner JSG, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F60\u20135.","journal-title":"AIDS"},{"issue":"3","key":"1470_CR48","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1468-1293.2006.00355.x","volume":"7","author":"Y Yuan","year":"2006","unstructured":"Yuan Y, L\u2019Italien G, Mukherjee J, Iloeje UH. Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort. HIV Med. 2006;7(3):156\u201362.","journal-title":"HIV Med"},{"issue":"5","key":"1470_CR49","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/00042560-200112150-00006","volume":"28","author":"A Ammassari","year":"2001","unstructured":"Ammassari A, Murri R, Pezzotti P, Trotta MP, Ravasio L, De Longis P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr. 2001;28(5):445\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"1470_CR50","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1056\/NEJMoa035103","volume":"349","author":"J Lawrence","year":"2003","unstructured":"Lawrence J, Mayers DL, Hullsiek KH, Collins G, Abrams DI, Reisler RB, et al. Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus. N Engl J Med. 2003;349(9):837\u201346.","journal-title":"N Engl J Med"},{"issue":"3","key":"1470_CR51","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11904-014-0214-z","volume":"11","author":"MJ Milloy","year":"2014","unstructured":"Milloy MJ, Montaner JSG, Wood E. Incarceration of people living with HIV\/AIDS: implications for treatment-as-prevention. Curr HIV AIDS Rep. 2014;11(3):308\u201316.","journal-title":"Curr HIV AIDS Rep"},{"issue":"4","key":"1470_CR52","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11904-012-0137-5","volume":"9","author":"MJ Milloy","year":"2012","unstructured":"Milloy MJ, Marshall BDL, Montaner J, Wood E. Housing status and the health of people living with HIV\/AIDS. Curr HIV AIDS Rep. 2012;9(4):364\u201374.","journal-title":"Curr HIV AIDS Rep"},{"issue":"9738","key":"1470_CR53","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S0140-6736(10)60958-0","volume":"376","author":"E Wood","year":"2010","unstructured":"Wood E, Werb D, Kazatchkine M, Kerr T, Hankins C, Gorna R, et al. Vienna declaration: a call for evidence-based drug policies. Lancet. 2010;376(9738):310\u20132.","journal-title":"Lancet"},{"key":"1470_CR54","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1097\/QAI.0b013e3181f9c0de","volume":"55","author":"D Wolfe","year":"2010","unstructured":"Wolfe D, Cohen J. Human rights and HIV prevention, treatment, and care for people who inject drugs: key principles and research needs. J Acquir Immune Defic Syndr. 2010;55:S56\u201362.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-016-1470-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-016-1470-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-016-1470-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-016-1470-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:44:48Z","timestamp":1744173888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-016-1470-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,28]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1470"],"URL":"https:\/\/doi.org\/10.1007\/s10461-016-1470-2","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,28]]},"assertion":[{"value":"28 June 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"We declare that we have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"All research activities performed for this study were approved by the University of British Columbia and Providence Health Care research ethics board and undertaken in accordance with the Tri-Council policy statement for research involving human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individuals participating in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}